Leprosy Clinical Trial
Official title:
Clinic-Epidemiological Evaluation of Ulcers in Leprosy Patients and the Use of Low Level Laser Therapy: a Randomized Clinical Trial
Verified date | March 2009 |
Source | Para Federal University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Brazil: Ethics Committee |
Study type | Interventional |
Neuropathic ulcers are common sequelae of leprosy. The objectives of this study are to analyze the clinic-epidemiological characteristics of patients attended at one specialized dressing service from a leprosy-endemic region of the Brazilian Amazon and to evaluate the effect of Low Level Laser Therapy on wound healing of these patients.
Status | Completed |
Enrollment | 25 |
Est. completion date | April 2008 |
Est. primary completion date | January 2008 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - presented with neuropathic ulcer - attended at least 3 weekly appointments at the dressing service of UREMC - completed specific multi-drug therapy for M. leprae - gave written informed consent to participate in the study Exclusion Criteria: - clinically detectable infection in the ulcer - use of drugs, like corticosteroids that could interfere with the wound healing process - use of special dressings like hydrocolloid, calcium alginate, activated carbon or any kind of therapeutic procedure different from that used routinely for both groups of study - non-attendance to therapeutic program (six sequential times or nine intercalated) - pregnancy - discomfort during treatment procedure |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Brazil | Dr. Marcello Candia Reference Unit in Sanitary Dermatology of the State of Pará in Brazil (UREMC) | Marituba | Pará |
Lead Sponsor | Collaborator |
---|---|
Para Federal University |
Brazil,
Flemming K, Cullum N. Laser therapy for venous leg ulcers. Cochrane Database Syst Rev. 2000;(2):CD001182. Review. Update in: Cochrane Database Syst Rev. 2014;7:CD001182. — View Citation
Franek A, Król P, Kucharzewski M. Does low output laser stimulation enhance the healing of crural ulceration? Some critical remarks. Med Eng Phys. 2002 Nov;24(9):607-15. — View Citation
Hopkins JT, McLoda TA, Seegmiller JG, David Baxter G. Low-Level Laser Therapy Facilitates Superficial Wound Healing in Humans: A Triple-Blind, Sham-Controlled Study. J Athl Train. 2004 Sep;39(3):223-229. — View Citation
Lucas C, van Gemert MJ, de Haan RJ. Efficacy of low-level laser therapy in the management of stage III decubitus ulcers: a prospective, observer-blinded multicentre randomised clinical trial. Lasers Med Sci. 2003;18(2):72-7. — View Citation
Pereira AN, Eduardo Cde P, Matson E, Marques MM. Effect of low-power laser irradiation on cell growth and procollagen synthesis of cultured fibroblasts. Lasers Surg Med. 2002;31(4):263-7. — View Citation
Schindl A, Schindl M, Pernerstorfer-Schön H, Mossbacher U, Schindl L. Low intensity laser irradiation in the treatment of recalcitrant radiation ulcers in patients with breast cancer--long-term results of 3 cases. Photodermatol Photoimmunol Photomed. 2000 Feb;16(1):34-7. — View Citation
Schubert V. Effects of phototherapy on pressure ulcer healing in elderly patients after a falling trauma. A prospective, randomized, controlled study. Photodermatol Photoimmunol Photomed. 2001 Feb;17(1):32-8. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Wound healing | Biweekly until the end of the 12 week treatment period. | No | |
Secondary | Ulcer surface area, depth and PUSH tool score. | Biweekly until the end of the 12 week treatment period or until complete cicatrization of the treated ulcer. | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03302897 -
Phase 1 LEP-F1 + GLA-SE Vaccine Trial in Healthy Adult Volunteers
|
Phase 1 | |
Recruiting |
NCT05243654 -
Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy
|
Phase 2 | |
Completed |
NCT05091216 -
The Effects of Traditional Chinese Medicine Mouthwash Solutions on the Oral Health of Leprosy Patients
|
N/A | |
Recruiting |
NCT06222372 -
Novel Interventions and Diagnostic Tests for Leprosy
|
N/A | |
Terminated |
NCT03084614 -
CD8 Reactivity to Microorganisms in Blood and Breast Milk
|
||
Recruiting |
NCT05597280 -
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy
|
Phase 3 | |
Terminated |
NCT01751503 -
Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer
|
N/A | |
Active, not recruiting |
NCT03324035 -
Treatment of Neuropathic Pain in Leprosy
|
Phase 3 | |
Completed |
NCT03683745 -
Integrated Mapping of Skin-presenting Neglected Tropical Diseases in Liberia
|
||
Recruiting |
NCT02550080 -
Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
|
Phase 4 | |
Completed |
NCT02484469 -
Impact of the Virtual Human Project on Team-based Learning: A Randomized-controlled Trial
|
N/A | |
Completed |
NCT01165840 -
Effect of Weight and/or Obesity on Dapsone Drug Concentrations
|
Phase 4 | |
Completed |
NCT00919542 -
Ciclosporin in the Management of New Erythema Nodosum Leprosum
|
Phase 2 | |
Completed |
NCT05406479 -
Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2)
|
Phase 2 | |
Recruiting |
NCT03807362 -
CC-11050 Trial in Nepalese Patients With Erythema Nodosum Leprosum
|
Phase 2 | |
Completed |
NCT01006759 -
Prevention of Disability: Proposal for a Guidance Manual for Leprosy Patients
|
Phase 1 | |
Completed |
NCT03662022 -
Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar
|
Phase 3 | |
Completed |
NCT01920750 -
Leprosy Skin Test Antigens Phase 1
|
Phase 1 | |
Recruiting |
NCT06416033 -
Serum Irisin Level In Leprosy Patients
|
||
Not yet recruiting |
NCT03947437 -
Phase 1b/2a Trial to Evaluate LEP-F1 + GLA-SE in Healthy Adults and Leprosy Patients
|
Phase 1/Phase 2 |